24.5
アフィニティとアビディティ
概要
抗体は、細胞、細菌、ウイルス、真菌などの表面に存在する毒素や物質と結合します。抗体が結合する物質を「抗原」と呼び、正確な結合部位を「エピトープ」と呼びます。抗体とエピトープの相互作用の強さを親和性（アフィニティ）といい、抗体が複数のエピトープで抗原と結合する場合、その相互作用の累積の強さをアビ…
免疫反応中、抗体は抗原と呼ばれる病原体の表面にある 特定のタンパク質に結合することによって、外来病原体を標的にして破壊します。これらの抗体 抗原相互作用は、病原体が他の細胞に感染するのを防ぎ、そして破壊のために病原体に目印をつけるために重要です。親和性という用語は、単一の抗体と単一のエピトープ、または抗原の一部との間の相互作用の強度を指しています。例えば、特定の抗原に対して高い親和性を有する抗体は 強力かつ安定な相互作用を有し、解離を妨げます。反対に，親和性の低い相互作用は 容易に解離します。様々な強さの抗体親和性により、免疫系は、風邪ウイルスなどの所与の病原体に対する 応答を最適化することが可能になります。例えば、免疫系が病原体に 初めて遭遇したとき、抗体 抗原相互作用の親和性は低いでしょう。しかし、同じ抗原に繰り返しさらされると、宿主は、より強くより速い免疫応答を おこなうため，宿主は 親和性を増して抗体を産生します。抗体の一部は多価なので，複数の抗原性エピトープに同時に結合することができます。この場合、これらの相互作用の 累積強度は結合活性と呼ばれます。通常，多価抗体と抗原との間の相互作用は、高結合活性，低親和性です。
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between affinity and avidity in antibody-antigen interactions?
Affinity measures the strength of interaction between a single antibody and a single epitope on an antigen. Avidity refers to the cumulative binding strength when a multivalent antibody binds multiple epitopes simultaneously. High avidity antibodies typically have low affinity for individual epitopes but achieve strong overall binding through multiple contact points.
Q2: How does antibody affinity change during repeated exposure to the same antigen?
During initial pathogen exposure, antibodies produced have low affinity for the antigen. However, repeated encounters trigger an adaptive selection process that produces antibodies with progressively higher affinity. This affinity maturation results in stronger and faster immune responses upon subsequent exposures to the same pathogen.
Q3: Why do multivalent antibodies like IgM have high avidity but low affinity?
IgM antibodies possess multiple binding sites recognizing the same epitope, creating high cumulative binding strength or avidity. However, individual binding interactions have low affinity. This design allows IgM to quickly recognize new antigens without requiring elaborate selection processes, making it ideal for initial immune responses.
Q4: What role does the epitope play in antibody-antigen binding?
An epitope is the precise binding site on an antigen where an antibody makes contact. The strength of interaction between an antibody and a specific epitope defines that antibody's affinity. Different epitopes on the same antigen can be recognized by different antibodies, allowing varied immune responses.
Q5: How does varying antibody affinity optimize the immune response to pathogens?
Low-affinity antibodies from initial exposures provide basic pathogen recognition and tagging for destruction. As the immune system encounters the same pathogen repeatedly, higher-affinity antibodies are produced, enabling stronger binding, more efficient pathogen neutralization, and faster immune responses during subsequent infections.
Q6: What is the functional advantage of IgM antibodies in early immune responses?
IgM antibodies are produced quickly during early immune responses because they do not undergo elaborate affinity selection processes. Their high avidity compensates for low individual binding affinity, allowing them to recognize new antigens effectively. IgM also triggers B cells to produce other antibody classes with higher affinity against newly identified antigens.
Q7: How do antibodies prevent pathogen infection and facilitate destruction?
Antibodies bind to antigens on pathogen surfaces through antibody-antigen interactions, preventing the pathogen from infecting other cells. Simultaneously, these bound antibodies tag pathogens for destruction by immune system components. The strength of these interactions, determined by affinity and avidity, directly influences the effectiveness of the immune response.